Detalles de la búsqueda
1.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759721
2.
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
Ann Surg
; 278(3): e540-e548, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453261
3.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636444
4.
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Br J Cancer
; 127(5): 957-967, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665778
5.
Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection.
Langenbecks Arch Surg
; 407(4): 1741-1750, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028737
6.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253871
7.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024268
8.
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancer.
Future Oncol
; 17(14): 1749-1759, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33464133
9.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
10.
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Br J Cancer
; 123(3): 403-409, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424148
11.
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells.
Invest New Drugs
; 38(1): 92-98, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31154566
12.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32698790
13.
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
Oncologist
; 22(5): 601-608, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28424324
14.
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
Br J Cancer
; 114(1): 30-6, 2016 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26575603
15.
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 21(8): 988-94, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27382031
16.
Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer.
Int J Cancer
; 146(9): 2652-2654, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970766
17.
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
Anticancer Drugs
; 24(9): 980-5, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23928570
18.
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor.
Anticancer Drugs
; 24(7): 759-64, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23695010
19.
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials.
Eur J Cancer
; 184: 106-116, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913832
20.
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm.
Crit Rev Oncol Hematol
; 186: 103985, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059274